Document and Entity Information
Document and Entity Information | Jun. 15, 2021 |
Cover [Abstract] | |
Entity Registrant Name | BELLICUM PHARMACEUTICALS, INC |
Security Exchange Name | NASDAQ |
Amendment Flag | false |
Entity Central Index Key | 0001358403 |
Document Type | 8-K |
Document Period End Date | Jun. 15, 2021 |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-36783 |
Entity Tax Identification Number | 20-1450200 |
Entity Address, Address Line One | 3730 Kirby Drive |
Entity Address, Address Line Two | Ste. 1200 |
Entity Address, City or Town | Houston |
Entity Address, State or Province | TX |
Entity Address, Postal Zip Code | 77098 |
City Area Code | 832 |
Local Phone Number | 384-1100 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, par value $0.01 per share |
Trading Symbol | BLCM |
Entity Emerging Growth Company | false |